Insider · CIK 0001181186
Wendy L Yarno
Files at INO (INOVIO PHARMACEUTICALS, INC.), IOVA (IOVANCE BIOTHERAPEUTICS, INC.), IDYA (IDEAYA Biosciences, Inc.), TARS (Tarsus Pharmaceuticals, Inc.). First filing -, latest -.
In brief
Wendy L Yarno files SEC Form 4 as director at INO (INOVIO PHARMACEUTICALS, INC.), and also at IOVA (IOVANCE BIOTHERAPEUTICS, INC.), IDYA (IDEAYA Biosciences, Inc.), TARS (Tarsus Pharmaceuticals, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Wendy L Yarno has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 21 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 15, 2026 | TARS Tarsus Pharmaceuticals, Inc. | MOption exercise Common Stock | +302 | - | - | 16,956 | 27 d ago |
| Sep 15, 2026 | TARS Tarsus Pharmaceuticals, Inc. | MOption exercise Restricted Stock Unitsderivative | -302 | $0.00 | $0 | 907 | 27 d ago |
| Jun 25, 2026 | TARS Tarsus Pharmaceuticals, Inc. | AGrant or award Stock Option (right to buy)derivative | +3,837 | $0.00 | $0 | 3,837 | Jun 29, 2026 |
| Jun 25, 2026 | TARS Tarsus Pharmaceuticals, Inc. | AGrant or award Restricted Stock Unitsderivative | +2,417 | $0.00 | $0 | 2,417 | Jun 29, 2026 |
| Jun 25, 2026 | TARS Tarsus Pharmaceuticals, Inc. | AGrant or award Restricted Stock Unitsderivative | +1,209 | $0.00 | $0 | 1,209 | Jun 29, 2026 |
| Jun 16, 2026 | IDYA IDEAYA Biosciences, Inc. | AGrant or award Stock Option (right to buy)derivative | +20,000 | $0.00 | $0 | 20,000 | Jun 18, 2026 |
| Jun 12, 2026 | TARS Tarsus Pharmaceuticals, Inc. | MOption exercise Common Stock | +2,954 | - | - | 16,654 | Jun 16, 2026 |
| Jun 12, 2026 | TARS Tarsus Pharmaceuticals, Inc. | MOption exercise Restricted Stock Unitsderivative | -2,954 | $0.00 | $0 | 0 | Jun 16, 2026 |
| May 20, 2026 | INO INOVIO PHARMACEUTICALS, INC. | AGrant or award Common Stock Optionsderivative | +41,800 | $0.00 | $0 | 41,800 | May 21, 2026 |
| May 20, 2026 | INO INOVIO PHARMACEUTICALS, INC. | AGrant or award Restricted Stock Unitderivative | +34,200 | $0.00 | $0 | 34,200 | May 21, 2026 |
| Jun 24, 2025 | IDYA IDEAYA Biosciences, Inc. | AGrant or award Stock Option (right to buy)derivative | +20,000 | $0.00 | $0 | 20,000 | Jun 26, 2025 |
| Jun 13, 2025 | IOVA IOVANCE BIOTHERAPEUTICS, INC. | AGrant or award Deferred Restricted Stock Unitderivative | +67,546 | $0.00 | $0 | 67,546 | Jun 17, 2025 |
| Jun 13, 2025 | TARS Tarsus Pharmaceuticals, Inc. | MOption exercise Common Stock | +3,350 | - | - | 13,700 | Jun 16, 2025 |
| Jun 12, 2025 | TARS Tarsus Pharmaceuticals, Inc. | AGrant or award Stock Option (right to buy)derivative | +4,540 | $0.00 | $0 | 4,540 | Jun 16, 2025 |
| Jun 12, 2025 | TARS Tarsus Pharmaceuticals, Inc. | AGrant or award Restricted Stock Unitsderivative | +2,954 | $0.00 | $0 | 2,954 | Jun 16, 2025 |
| Jun 13, 2025 | TARS Tarsus Pharmaceuticals, Inc. | MOption exercise Restricted Stock Unitsderivative | -3,350 | $0.00 | $0 | 0 | Jun 16, 2025 |
| May 21, 2025 | INO INOVIO PHARMACEUTICALS, INC. | MOption exercise Common Stock | +2,167 | - | - | 10,512 | May 21, 2025 |
| May 21, 2025 | INO INOVIO PHARMACEUTICALS, INC. | MOption exercise Restricted Stock Unitderivative | -2,167 | $0.00 | $0 | 0 | May 21, 2025 |
| Mar 1, 2024 | IOVA IOVANCE BIOTHERAPEUTICS, INC. | AGrant or award Deferred Restricted Stock Unitderivative | +25,000 | $0.00 | $0 | 25,000 | Mar 5, 2024 |
| Dec 2, 2023 | TARS Tarsus Pharmaceuticals, Inc. | MOption exercise Common Stock | +5,000 | - | - | 7,000 | Dec 5, 2023 |
| Dec 2, 2023 | TARS Tarsus Pharmaceuticals, Inc. | MOption exercise Restricted Stock Unitsderivative | -5,000 | $0.00 | $0 | 0 | Dec 5, 2023 |
Questions about Wendy L Yarno
Answered from the filings on this page, as of the latest one.
Is Wendy L Yarno buying or selling?
Wendy L Yarno has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Wendy L Yarno's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Wendy L Yarno has 0.
Where does Wendy L Yarno file Form 4?
Wendy L Yarno has filed Form 4 at INO (INOVIO PHARMACEUTICALS, INC.); IOVA (IOVANCE BIOTHERAPEUTICS, INC.); IDYA (IDEAYA Biosciences, Inc.); TARS (Tarsus Pharmaceuticals, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.